A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors

D. Mahadevan, R. Plummer, M. S. Squires, D. Rensvold, S. Kurtin, C. Pretzinger, T. Dragovich, J. Adams, V. Lock, D. M. Smith, D. Von Hoff, H. Calvert

Research output: Contribution to journal › Article › peer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science